Clinical trial
Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
NCT02423187 is registered in ClinicalTrials.gov with Eisai Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rabeprazole Specific Clinical Experience Investigation for the Long-term Combination Therapy With Low-dose Aspirin
- Lead sponsor
- Eisai Co., Ltd.
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 17, 2015
- Completion date
- October 30, 2017
- Enrollment
- 1,568 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
duodenal ulcer, gastric ulcer